Search research articles
Contact Us
Filters
Showing results (21-30 of 40) with videos related to
Page
of 4
Sort By:
Journal of Thoracic Disease
|
August 14, 2025
Using Vizient database for benchmarking pulmonary resection outcomes
Anuj Shah, Duc T Nguyen, Swetha Mulpur, et al.
Molecular Carcinogenesis
|
March 23, 2022
Transglutaminase 2 enhances hepatocyte growth factor signaling to drive the mesothelioma cancer cell phenotype
Warren Naselsky, Gautam Adhikary, Suruchi Shrestha, et al.
Bioorganic & Medicinal Chemistry
|
December 1, 1995
Synthesis of a selective alpha-2A adrenoceptor antagonist, BRL 48962, and its characterization at cloned human alpha-adrenoceptors
L J Beeley, J M Berge, H Chapman, et al.
Surgical Endoscopy
|
June 30, 2026
Comparative long-term outcomes of Heller myotomy and peroral endoscopic myotomy
Samar Semaan, Cynthia Kassab, Warren C Naselsky, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
June 1, 1997
Pharmacological characterization of the uroselective alpha-1 antagonist Rec 15/2739 (SB 216469): role of the alpha-1L adrenoceptor in tissue selectivity, part I
A Leonardi, J P Hieble, L Guarneri, et al.
Molecular Carcinogenesis
|
December 23, 2022
Mesothelioma cancer cells are glutamine addicted and glutamine restriction reduces YAP1 signaling to attenuate tumor formation
Gautam Adhikary, Suruchi Shrestha, Warren Naselsky, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology
|
November 19, 2004
Urotensin-II-mediated cardiomyocyte hypertrophy: effect of receptor antagonism and role of inflammatory mediators
Douglas G Johns, Zhaohui Ao, Diane Naselsky, et al.
Peptides
|
September 8, 2004
Differential levels of "urotensin-II-like" activity determined by radio-receptor and radioimmuno-assays
Nambi Aiyar, Brian Guida, Zhaohui Ao, et al.
Indian Journal of Thoracic and Cardiovascular Surgery
|
July 15, 2026
Management of Harlequin syndrome in veno-arterial extracorporeal membrane oxygenation
Justin Robinson, Jason Ejimogu, Warren Naselsky, et al.
Perfusion
|
November 23, 2024
Non-intensive care unit feasibility for ambulatory veno-venous extracorporeal membrane oxygenation patients
Aakash Shah, Stephen Stachnik, Joshua L Leibowitz, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 40) with videos related to
Sort By:
Page
of 4
Journal of Thoracic Disease
|
August 14, 2025
Using Vizient database for benchmarking pulmonary resection outcomes
Anuj Shah, Duc T Nguyen, Swetha Mulpur, et al.
Molecular Carcinogenesis
|
March 23, 2022
Transglutaminase 2 enhances hepatocyte growth factor signaling to drive the mesothelioma cancer cell phenotype
Warren Naselsky, Gautam Adhikary, Suruchi Shrestha, et al.
Bioorganic & Medicinal Chemistry
|
December 1, 1995
Synthesis of a selective alpha-2A adrenoceptor antagonist, BRL 48962, and its characterization at cloned human alpha-adrenoceptors
L J Beeley, J M Berge, H Chapman, et al.
Surgical Endoscopy
|
June 30, 2026
Comparative long-term outcomes of Heller myotomy and peroral endoscopic myotomy
Samar Semaan, Cynthia Kassab, Warren C Naselsky, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
June 1, 1997
Pharmacological characterization of the uroselective alpha-1 antagonist Rec 15/2739 (SB 216469): role of the alpha-1L adrenoceptor in tissue selectivity, part I
A Leonardi, J P Hieble, L Guarneri, et al.
Molecular Carcinogenesis
|
December 23, 2022
Mesothelioma cancer cells are glutamine addicted and glutamine restriction reduces YAP1 signaling to attenuate tumor formation
Gautam Adhikary, Suruchi Shrestha, Warren Naselsky, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology
|
November 19, 2004
Urotensin-II-mediated cardiomyocyte hypertrophy: effect of receptor antagonism and role of inflammatory mediators
Douglas G Johns, Zhaohui Ao, Diane Naselsky, et al.
Peptides
|
September 8, 2004
Differential levels of "urotensin-II-like" activity determined by radio-receptor and radioimmuno-assays
Nambi Aiyar, Brian Guida, Zhaohui Ao, et al.
Indian Journal of Thoracic and Cardiovascular Surgery
|
July 15, 2026
Management of Harlequin syndrome in veno-arterial extracorporeal membrane oxygenation
Justin Robinson, Jason Ejimogu, Warren Naselsky, et al.
Perfusion
|
November 23, 2024
Non-intensive care unit feasibility for ambulatory veno-venous extracorporeal membrane oxygenation patients
Aakash Shah, Stephen Stachnik, Joshua L Leibowitz, et al.
Page
of 4